-
Since 1 October 2024, Australian pharmacists have been permitted to stock and supply certain therapeutic vaping products as Schedule 3 (Pharmacist Only) medicines. Bay Pharma partners with pharmacies to support the compliant supply and distribution of notified therapeutic vaping goods across Australia. We provide operational, regulatory, and supply chain support in alignment with current legislative and regulatory requirements. Product-specific information and resources are made available through appropriate healthcare professional channels.
Information for Pharmacists
This portal has been designed exclusively for pharmacists and healthcare professionals. Here, you will find a range of downloadable resources including product brochures and other collateral to support in-practice education and patient engagement.
These materials are intended to assist in delivering evidence-informed care, promoting safe and effective nicotine cessation strategies, and ensuring patients are well supported throughout their quit journey.
Please get in touch to request a Bay Pharma information pack.
-
Pharmaceutical Society of Australia - Professional Practice Guidelines
Learn MoreThe PSA has produced professional practice guidelines for the management of nicotine dependence and smoking cessation.
-
Information for Pharmacists (TGA)
Learn MoreLearn about recent changes to the regulation of therapeutic vaping goods in Australia, including what these changes mean for the sourcing, supply, and dispensing of these products through pharmacies and authorised healthcare settings.
-
TGA Notified Therapeutic Vaping products
TGA Notified ProductsThis page contains a list of therapeutic vaping goods, including vaping substances, vaping accessories, and vaping devices that sponsors have notified the Therapeutic Goods Administration that the goods comply with applicable Australian standards and requirements for lawful supply in Australia.
Informational Booklet & Catalogue
Bay Pharma provides pharmacists with a dedicated resource booklet featuring the full product range, key operational procedures and patient support guidance. The booklet also outlines the broader public health context of therapeutic vaping goods and introduces a structured Quit Step Program designed to support smoking cessation and progression toward nicotine independence.
Key features include:
- Clear procedures
- Guidance on selecting and recommending suitable products
- Consultation tips to enhance patient engagement and outcomes
- Downloadable reference material for quick support
- Information about how to safely and effectively use the products
LULA - Quick Reference Guide
LULA is a therapeutic vaping range designed to provide simplicity, consistency, and ease of use. The LULA Closed Pod System offers patients a convenient, ready-to-use option with pre-filled pods intended to support smoking cessation and the management of nicotine dependence.
This guide has been developed to assist pharmacists in providing clear and practical counselling to patients. It includes key product information, usage instructions, safety considerations, and storage guidance to support appropriate use.
CHOSEN - Quick Reference Guide
For patients seeking a more personalised, flexible, and less costly therapeutic option.
The LULA Refillable Pod System used in combination with CHOSEN Vapouriser Liquids provides an open system solution designed to support smoking cessation and nicotine dependence management.
This refillable format offers a more economical and sustainable approach for patients engaged in a gradual nicotine reduction journey and working toward long-term nicotine independence.
This guide has been developed to assist pharmacists in providing clear and practical counselling to patients. It includes key product information, usage instructions, safety considerations, and storage guidance to support appropriate use.
THESE PRODUCTS CONTAIN NICOTINE, WHICH IS A HIGHLY ADDICTIVE SUBSTANCE.
-
LULA System
Download LULA Closed Pods CMI User ManualConsumer Medicine Information (CMI) - LULA Closed Pod System
-
CHOSEN Vapouriser Liquid
Download CHOSEN Vapouriser Liquid CMIConsumer Medicine Information (CMI) -
CHOSEN Vapouriser Liquid
Ordering Bay Pharma Products
For information on Bay Pharma products and ordering via our distributor CanView
Telehealth provider
Should a patient need to access a prescriber for higher strength nicotine
-
SAS-C Consult Guide
View & DownloadThis form can be used to determine if a patient is eligible for an S3 therapeutic vaping product, gain their informed consent and record the consultation.
-
SAS-C Submission Guide
View & DownloadDownload a structured, visual and textual instructions to support your SAS-C obligations.
-
SAS-C Register Sheet
View & DownloadA downloadable SAS-C register sheet. This structured tool supports accurate documentation of patient access under the Special Access Scheme Category C, promoting compliance and streamlined record-keeping.
-
Webinar
ViewBay Pharma supports continuous education with access to an informative webinar on the history of tobacco, vaping, and the medical access pathway in Australia
-
Cochrane Review
View & DownloadEvidence-based review of clinical studies on the effectiveness and safety of e-cigarettes for quitting smoking.
-
Physicians Review
Royal College of Physicians Evidence Review RACGP GuidanceExpert guidance on vaping’s role in tobacco harm reduction, health risks, and public health recommendations.
-
Proudly Independent
Bay Pharma has no affiliation with the tobacco industry, their affiliates, or any organisations or individuals engaged in lobbying on their behalf.
-
Accessed Across Australia
Find a pharmacy stockistBay Pharma products are available across Australia through established distribution networks, in line with applicable regulatory standards.
-
Training & Consulting
Therapeutic Nicotine Vaping Products encompass a range of product types and may involve varying levels of complexity. We provide information and support to healthcare professionals to assist with their understanding and use within clinical care.
If you would like to learn more about the Therapeutic vaping category our team can provide educational sessions for you and your team.
Contact usIf you are interested in stocking our products - Contact us today: 1300 938 651
Collapsible content
Disclaimer
In Australia, nicotine-containing vaping products (NVPs) are classified as therapeutic goods by the Therapeutic Goods Administration (TGA) and are regulated accordingly. These products, including those supplied by Bay Pharma, are not registered on the Australian Register of Therapeutic Goods (ARTG) and are therefore considered unapproved therapeutic goods. NVPs have not been approved as smoking cessation or nicotine dependence treatments in Australia.
NVPs are not first-line treatments for smoking cessation or nicotine dependence. However, they may be considered for individuals who have not achieved cessation with approved treatments and who remain motivated to quit, following consultation with a healthcare practitioner. Their use should be guided by an evidence-informed, shared decision-making process, avoidning dual use alongside tobacco smoking.
Supply is restricted to pharmacies and other authorised healthcare settings in accordance with relevant scheduling, quality, and labelling requirements. These products are not supplied for recreational use.
Partner In Quality